Serological diagnosis was examined for deep mycotic infections, especially candidiasis. Candida antigen and antibody researches were made by means of CAND-TEC (RAMCO Co., Ltd) and passive hemagglutination test (PHA) (Roche Co., Ltd), respectively, and simultaneous determinations were made of D-arabinitol, a fungal metabolite and (1-3)-β-D-glucan, fungal parietal component.
1) For normal subjects, 1 of 173 cases (0.6%), 5 of 200 cases (2.5%) and 7 of 157 cases (4.5%) showed <1: 4, 320 × and <11, μmol/1 for CAND-TEC,
Candida antibody and D-arabinitol, respectively, and values above these were judged positive.
2) Of the 171 patients with pyrexia refractory to general antibiotic agents, who were treated at our Department and related institutions from November 1988 to March 1990, 41 with obvious
Candida infections were CAND-TEC,
Candida antibody, D-arabinitol and (1-3)-β-D-glucan positive in 33 (80.5%), 21 (51.2%), 29 (70.7%) and 13 cases (56.6%), respectively. At least one item-positive patient was as high as 97.4%. On the other hand, in the group having no
Candida infection at all, 1 of 57 cases on CAND-TEC (1.7%) and 10 of 55 cases on Candida antibody (18.2%) were positive, indicating significant differences from the surely
Candida-infectious group.
3) Comparative examination of CAND-TEC and other testing methods revealed a correlation of CAND-TEC with D-arabinitol in cases showing 1: 4 and 1: 8>, but not other significant difference.
4) Also in the respiratory
Candida infectious group strongly suspected of
Candida infection and the group suspected of urinary Candida infection, CAND-TEC, D-arabinitol and (1-3)-β-D-glucan showed significantly high positivity compared with the group having no
Candida infection.
The above results suggest that≥ 1: 4with CAND-TEC is significant for serological diagnosis of candidiasis and that a combined use of CAND-TEC with some other testing method makes early serological diagnosis of
Candida infection possible.
View full abstract